|
Volumn , Issue 53, 1996, Pages
|
A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
GROWTH HORMONE;
SOMATOMEDIN BINDING PROTEIN;
SOMATOMEDIN C;
ADOLESCENT;
BODY GROWTH;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
FEMALE;
GRAFT REJECTION;
GROWTH RETARDATION;
HORMONAL THERAPY;
HUMAN;
KIDNEY TRANSPLANTATION;
MALE;
PRIORITY JOURNAL;
RENAL OSTEODYSTROPHY;
SUBCUTANEOUS DRUG ADMINISTRATION;
ARTICLE;
BLOOD;
CARBOHYDRATE METABOLISM;
CHRONIC KIDNEY FAILURE;
METABOLISM;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ADOLESCENT;
CARBOHYDRATE METABOLISM;
CHILD;
DOUBLE-BLIND METHOD;
FEMALE;
GROWTH HORMONE;
HUMANS;
INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS;
INSULIN-LIKE GROWTH FACTOR I;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MALE;
|
EID: 0030031253
PISSN: 00986577
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (87)
|
References (0)
|